Lifecore Biomedical Inc
LFCR7.360USD
+0.370+5.30%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
272.51MCap. mercado
PérdidaP/E TTM
Más Datos de Lifecore Biomedical Inc Compañía
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
Información de la empresa
Símbolo de cotizaciónLFCR
Nombre de la empresaLifecore Biomedical Inc
Fecha de salida a bolsaFeb 15, 1996
Director ejecutivoMr. Paul Josephs
Número de empleados524
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 15
Dirección3515 Lyman Boulevard
CiudadCHASKA
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal55318
Teléfono19523684300
Sitio Webhttps://www.lifecore.com/
Símbolo de cotizaciónLFCR
Fecha de salida a bolsaFeb 15, 1996
Director ejecutivoMr. Paul Josephs
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thomas (Tom) Salus
Mr. Thomas (Tom) Salus
Chief Legal and Administrative Officer , Corporate Secretary
Chief Legal and Administrative Officer , Corporate Secretary
240.98K
+12.08%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
133.33K
+249.16%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer, Executive Vice President, Company Secretary
Chief Financial Officer, Executive Vice President, Company Secretary
97.12K
+76.82%
Ms. Katrina Lovas (Kathy) Houde
Ms. Katrina Lovas (Kathy) Houde
Independent Chairman of the Board
Independent Chairman of the Board
79.41K
+32.56%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
79.17K
+32.69%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
44.06K
+79.44%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
19.51K
--
Ms. Jackie Klecker
Ms. Jackie Klecker
Executive Vice President - Quality and Development Services
Executive Vice President - Quality and Development Services
--
--
Mr. Christopher Kiper
Mr. Christopher Kiper
Independent Director
Independent Director
--
--
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thomas (Tom) Salus
Mr. Thomas (Tom) Salus
Chief Legal and Administrative Officer , Corporate Secretary
Chief Legal and Administrative Officer , Corporate Secretary
240.98K
+12.08%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
133.33K
+249.16%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer, Executive Vice President, Company Secretary
Chief Financial Officer, Executive Vice President, Company Secretary
97.12K
+76.82%
Ms. Katrina Lovas (Kathy) Houde
Ms. Katrina Lovas (Kathy) Houde
Independent Chairman of the Board
Independent Chairman of the Board
79.41K
+32.56%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
79.17K
+32.69%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
44.06K
+79.44%
Desglose de ingresos
Divisa: USDActualizado: mar., 4 de mar
Divisa: USDActualizado: mar., 4 de mar
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
16.40M
59.42%
Switzerland
6.80M
24.64%
Ireland
1.10M
3.99%
Australia
1.10M
3.99%
Canada
700.00K
2.54%
Other
1.50M
5.43%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
Estadísticas de accionistas
Actualizado: sáb., 12 de jul
Actualizado: sáb., 12 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Wynnefield Capital, Inc.
12.70%
Legion Partners Asset Management, LLC
11.97%
Greenhaven Road Investment Management, L.P.
9.77%
325 Capital LLC
5.84%
Laughing Water Capital, LP
5.13%
Other
54.59%
Accionistas
Accionistas
Proporción
Wynnefield Capital, Inc.
12.70%
Legion Partners Asset Management, LLC
11.97%
Greenhaven Road Investment Management, L.P.
9.77%
325 Capital LLC
5.84%
Laughing Water Capital, LP
5.13%
Other
54.59%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
28.40%
Investment Advisor
23.46%
Investment Advisor/Hedge Fund
18.13%
Individual Investor
2.05%
Research Firm
2.01%
Venture Capital
0.25%
Bank and Trust
0.12%
Insurance Company
0.02%
Other
25.54%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
211
27.29M
73.73%
-2.75M
2025Q1
229
29.94M
81.56%
-2.38M
2024Q4
243
30.30M
82.90%
-2.02M
2024Q3
234
26.35M
84.61%
-494.37K
2024Q2
224
23.91M
77.61%
-4.44M
2024Q1
225
24.56M
80.40%
-3.68M
2023Q4
221
23.64M
77.94%
-3.68M
2023Q3
229
20.71M
68.28%
-6.48M
2023Q2
237
20.72M
68.32%
-8.44M
2023Q1
244
23.24M
76.67%
-6.53M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Wynnefield Capital, Inc.
4.70M
12.7%
--
--
Mar 31, 2025
Legion Partners Asset Management, LLC
4.43M
11.97%
--
--
Mar 31, 2025
Greenhaven Road Investment Management, L.P.
3.62M
9.77%
--
--
Mar 31, 2025
325 Capital LLC
2.16M
5.84%
+1.37M
+172.80%
Mar 31, 2025
Laughing Water Capital, LP
1.90M
5.13%
+321.80K
+20.39%
Feb 18, 2025
David Capital Partners, LLC
1.80M
4.87%
+148.00K
+8.94%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
1.63M
4.41%
+134.35K
+8.97%
Mar 31, 2025
The Vanguard Group, Inc.
1.55M
4.18%
+15.96K
+1.04%
Mar 31, 2025
Geode Capital Management, L.L.C.
750.50K
2.03%
+64.75K
+9.44%
Mar 31, 2025
Morgan Stanley & Co. LLC
617.00K
1.67%
-19.06K
-3.00%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
Invesco Dorsey Wright SmallCap Momentum ETF
0.44%
iShares Micro-Cap ETF
0.05%
WisdomTree US SmallCap Fund
0.03%
Motley Fool Next Index ETF
0.02%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Ver más
Invesco Dorsey Wright SmallCap Momentum ETF
Proporción0.44%
iShares Micro-Cap ETF
Proporción0.05%
WisdomTree US SmallCap Fund
Proporción0.03%
Motley Fool Next Index ETF
Proporción0.02%
iShares Russell 2000 ETF
Proporción0.01%
Global X Russell 2000 ETF
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.01%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
